ARTHROPLASTY
Efficacy of Floseal vs. tranexamic acid vs. control for bleeding control in patients undergoing TKA
Clinics (Sao Paulo). 2019 Nov 25;74:e1186.90 patients scheduled for a total knee arthroplasty were randomized to receive Floseal, tranexamic acid or control for the reduction of peri-operative bleeding. Outcomes of interest included aspirated blood volume, pad weight, incidence of transfusion, drainage volume, hemoglobin decrease, total measured bleeding and range of motion. Follow up was performed for a minimum of 12 months. Results revealed significantly greater drainage output, hemoglobin decrease, total measured bleeding, aspirated blood volume and worse range of motion in the control group compared to the Floseal and tranexamic acid groups. Additionally, the Floseal group significantly outperformed the tranexamic acid group in drainage output and range of motion.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
